Our recent study demonstrated that an imbalance of Tfr and Tfh cell activation is related to disease activity in patients with SLE, and IL-2 restores the balance between Tfh and Tfr cells through conversion of memory Tfh cells to functional Tfr cells [4]. This evidence concerns the gene TFRC and systemic lupus erythematosus.